An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes (vol 381, pg 603, 2019)

被引：5
作者：
不详
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 06期
关键词：
D O I：
10.1056/NEJMx190033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Medical assistance in dying followed by organ donation is new to North America. If chosen, this path offers potential donors the opportunity to fulfill their last requests and may also affect transplant waiting lists. This letter discusses organ donation after euthanasia and its implications.
引用
收藏
页码：586 / 586
页数：1
相关论文
共 1 条
  • [1] An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
    Herold, Kevan C.
    Bundy, Brian N.
    Long, S. Alice
    Bluestone, Jeffrey A.
    DiMeglio, Linda A.
    Dufort, Matthew J.
    Gitelman, Stephen E.
    Gottlieb, Peter A.
    Krischer, Jeffrey P.
    Linsley, Peter S.
    Marks, Jennifer B.
    Moore, Wayne
    Moran, Antoinette
    Rodriguez, Henry
    Russell, William E.
    Schatz, Desmond
    Skyler, Jay S.
    Tsalikian, Eva
    Wherrett, Diane K.
    Ziegler, Anette-Gabriele
    Greenbaum, Carla J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) : 603 - 613
1